Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2023 Volume 26 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2023 Volume 26 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery

  • Authors:
    • Sijia Yu
    • Xiaoli Dong
    • Wenguang Lai
    • Hongyu Lu
    • Yun Xie
    • Jun-Yan Xu
    • Yewen Zeng
    • Kedong Han
    • Jinqiang Liang
    • Jin Liu
    • Yong Liu
    • Jiyan Chen
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Department of Cardiology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570102, P.R. China, Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China, Guangdong Provincial Key Laboratory of Laboratory Animals, Guangdong Laboratory Animal Monitoring Institute, Guangzhou, Guangdong 523136, P.R. China, Department of Cardiology, Maoming People's Hospital, Maoming, Guangdong 525000, P.R. China, Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, Hainan 570228, P.R. China
    Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 321
    |
    Published online on: May 15, 2023
       https://doi.org/10.3892/etm.2023.12020
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute kidney injury (AKI) is a common complication after acute myocardial infarction (AMI) in clinical practice, and the majority of previous preclinical models were induced by a single factor. The objective of the present study was to establish a stable preclinic model of AKI induced by contrast media (CM) with acute myocardial ischemia reperfusion surgery and to identify the effect of oxidative stress on kidney injury. Rats were treated individually or with CM or myocardial ischemia reperfusion surgery. Renal baseline and AKI parameters, the level of oxidative stress and histopathological images were examined along with AKI biomarkers. Results showed the incidence of AKI in the CM group and ischemia reperfusion injury (IRI) group was 40%, χ2 test (P<0.05 vs. CM‑IRI) and 35%, χ2 test (P<0.05 vs. CM‑IRI) and the combination group had the highest incidence rate 75%. IRI surgery combined with CM diminished kidney function and induced oxidative stress by increasing creatinine, blood urea nitrogen and reactive oxygen species levels. Western blotting showed that the early AKI biomarker of NGAL and KIM‑1 increased and that the combination group had the highest value. Pathology damage exhibited severe kidney damage in the combination group compared with other control groups. The present research established a reliable preclinic model of post‑AMI AKI with a stable and high postoperative AKI rate. Additionally, CM was demonstrated to exacerbate AKI caused by acute myocardial infarction through oxidative stress and, thus, oxidative stress may be a potential therapeutic target.

Introduction

Acute kidney injury (AKI) is a common complication in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI), especially higher in acute myocardial infarction (AMI), with a prevalence ranging from 7.1 to 18.69% (1,2), and it raises the mortality risk of AMI patients by a factor of 2 to 20 times (3-6).

Current prevention strategy for post-AMI AKI patients mainly focused on minimizing the volume of iodinated radiocontrast media and optimizing periprocedural intravenous hydration. Indeed, previous research has indicated that post-AMI AKI was related to various complicated pathophysiological changes, which include contrast media inducing hypoxic injury in renal tubular epithelial cells, oxidative stress inducing the increase of oxygen free radicals, and vasoconstriction (7). Preclinical models of post-AMI AKI are needed to better clarify the underlying mechanisms and may therefore help to find therapeutic targets.

The majority of previous animal models, such as cisplatin-induced AKI, bilateral nephrectomy or renal ischemia-reperfusion injury induced AKI, and contrast-induced AKI model, are insufficient to mimic the clinical characteristics of post-AMI AKI because they primarily focused on one single factor that causes kidney damage, ignoring the effect of myocardial injury influence on kidney (8). Thus, basis on previous models, we establish an animal model of post-AMI AKI by combining IRI surgery with CM that closely resembles the clinical situation. To investigate the reliability and stability of the CM-IRI model, we also constructed single factor model of CM or IRI surgery, compared the incidence rate of AKI in two definitions, as well as assessed the role of oxidative stress and the extent of kidney injury.

Materials and methods

Animals

Animal studies were carried out in accordance with China's National Guidelines for The Care and Use of Laboratory Animals and were approved by the Animal Ethics Committee of Guangdong Provincial People's Hospital (Ethics No. GDRECKY2020-266-01). Adult male Sprague-Dawley rats (200-250 g) were purchased from Guangdong Laboratory Animals Monitoring Institute [License No SYXK (Yue) 2021-0122] and were given at least a week to acclimate before the study began. The rats were maintained at 2 or 3 rats/cage, given unrestricted standard diet and sterile water, housed at a temperature at 25˚C as well as a 12:12 light-dark cycle. Meanwhile, the pad of rats was observed and replaced daily.

Study design and groups

The rats were divided into four groups, as shown in Fig. 1. (1) SHAM: sham operation + normal saline (NS, 15 ml/kg); (2) CM: sham operation + contrast media (ioprolamine, 15 ml/kg); (3) IRI: IRI surgery + normal saline (NS, 15 ml/kg); (4) CM-IRI: IRI surgery + contrast media (ioprolamine, 15 ml/kg). After fast and water restriction for 24 h before surgery, rats were weighed and anaesthetized using 50 mg/kg pentobarbital sodium and 4 mg/kg xylazine hydrochloride, intraperitoneally. Then rats received endotracheal intubation and monitored cardiac rhythm with a typical lead II electrocardiogram. After that, rats were given a 15 ml/kg injection of contrast media or normal saline through the tail vein. Myocardial ischemia-reperfusion surgery was performed as previously described (9). Briefly, a left thoracotomy was performed in the fourth intercostal space, and the pericardium was removed to expose the heart, after which the left anterior descending (LAD) coronary artery was ligated for 45 min and repercussed for 2 h. After 24 h of the operation, 1 ml blood was collected from the tail vein, then all the rats used in the experiment were euthanized by an overdose of sodium pentobarbital 100 and 8 mg/kg xylazine hydrochloride intraperitoneally and confirmed by the disappear of pupillary reflex to light, respiration and heartbeat. Finally, heart and kidneys were removed for the following detection and histological staining (Fig. 2).

Figure 1

Workflow of the study. A total of 45 rats were divided into four groups: i) SHAM: NS (15 ml/kg) + sham operation; ii) CM: CM (15 ml/kg) + sham operation; iii) IRI: NS (15 ml/kg) + IRI surgery; and iv) CM-IRI: CM (15 ml/kg) + IRI surgery. Blood, heart and kidneys were removed for the following detection and histological staining. NS, normal saline; CM, contrast media; IRI, ischemia reperfusion injury.

Figure 2

Detailed operation process of contrast media-ischemia reperfusion injury group.

Renal function analysis

Blood samples were collected in a sodium citrate tube and centrifuged at 2,500 g for 15 min to separate the serum. Serum creatinine (Scr) and blood urea nitrogen (BUN) levels were determined using an automatic biochemical analyzer. The level of eGFR (estimated glomerular filtration rate) was calculated based on equation (10). The diagnosis of AKI was defined as an absolute increase in the serum creatinine ≥0.5 mg/dl (44.2 µmol/l) or a relative increase ≥25% from the baseline within 72 h after contrast administration according to the European Society of Urogenital Radiology (ESUR) criteria (11). And Kidney Disease Improving Global Outcomes (KDIGO) defined AKI as an increase in Scr >0.3 mg/dl within 48 h or a 50% increase from the baseline within 7 days (12).

Hematoxylin and eosin staining

Kidney was excised and fixed in 4% formaldehyde for 48 h, then embedded in paraffin and each slide was cut into 4 µm thick sections. Dehydrated sections with gradient alcohol after rinsing with water for 30 min. Subsequently, continuous slices were stained with hematoxylin and eosin (HE) and determined under light microscopy (13).

Measurement of reactive oxygen species (ROS) level in kidney tissue

After the perfusion of kidney, half of left fresh kidney tissue was isolated and ground in a sample freeze grinding machine (LukyM-1). The abrasive solution was centrifuged for 10 min (4˚C, 5,000 rpm) to collect the supernatant. ROS level was determined by the ROS assay kit (Bestbio Assay BB-470512). 190 microliters of homogenate supernatant were added to the 96-well plate, and mixed with O13 reactive oxygen species probe then incubated the plate at 37˚C for 30 min. Finally, the fluorescein intensity was detected using excitation at 510 nm and emission at 610 nm wavelengths on a microplate reader.

Western Blotting Analysis

Total protein was extracted from left kidney tissues. A 12% separating gel and a 5% concentrated gel were configured separately based on the measured protein molecular weight. After electrophoresis, proteins were transferred onto the nitrate cellulose membrane. The primary anti-NGAL antibody (Abcam, ab216462) and anti-KIM-1 (Abcam, ab233720) antibody were incubated overnight, then the primary antibodies were washed away and the secondary antibodies were incubated. After 2 h, the secondary antibodies were washed away and the developer solution was added for development. Finally, the relative expression levels of proteins were obtained by comparing them with the grey levels of GAPDH internal reference proteins.

Immunohistochemistry Analysis

The tissues were fixed with 4% paraformaldehyde for 3-4 h before dehydration and sectioning. Waiting for the antigen repair solution to cool naturally to room temperature and probed with anti-NGAL (Abcam, ab216462) at 4˚C overnight and labeled with secondary antibodies. The DAB staining solution was configured with the appropriate concentration according to the instructions. The stained tissue sections were observed and analyzed under a light microscope.

Data Analysis

All data are expressed as the mean ± standard deviation (SD). Statistical analysis was performed using Graph Pad Prism (GraphPad Software, CA, USA). Data were analyzed for normality using the Shapiro-Wilk test. One-way ANOVA followed by post hoc Tukey test was used. The enumeration data were expressed as rate and analyzed by the Chi-square test. P-value < 0.05 was considered statistically significant.

Results

Baseline and AKI parameters for each experimental group

As shown in Table I, no significant differences in baseline parameters were observed among the four groups. Compared with sham group, the level of BUN and Scr was elevated and eGFR was decreased in CM, IRI and CM-IRI groups (Fig. 3A-C).

Figure 3

Level of postoperative renal function. (A) Representative the postoperative Scr level. (B) Representative the postoperative BUN level. (C) Representative the postoperative eGFR level. *P<0.05, **P<0.01, ***P<0.001. Scr, Serum creatinine; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; CM, contrast media; IRI, ischemia reperfusion injury.

Table I

AKI baseline parameters for each group.

Table I

AKI baseline parameters for each group.

ParameternScr (µmol/l)BUN (mmol/l)eGFR (µl/min)
SHAM2027.88±5.554.66±0.982,631.51±322.68
CM2033.63±6.895.02±1.192,213.95±394.25
IRI2034.00±16.394.74±1.602,436.47±885.52
CM-IRI2028.60±3.544.47±1.562,609.40±566.67

[i] Data presenting mean ± standard deviation. Scr, Serum creatinine; BUN, Blood urea nitrogen; eGFR, estimated glomerular filtration rate.

The incidence of acute kidney injury

The sample size is primarily based on the prior study on the AKI model (14). At the same time, in the pre-experiment, we assessed the incidence of AKI in each group in general, so we selected a total of 80 rats to meet the statistical analysis requirement as well as to better compared the incidence of AKI in each group. Preoperative and postoperative levels of creatinine were used to determine the prevalence of AKI. As shown in Table II, the incidences of AKI rates were 40, 35 and 75% based on the ESUR criterion, and were 25, 25 and 55% in each group based on the KDIGO criterion, CM-IRI group has the highest AKI incidence rate.

Table II

Incidence rate of AKI for each group.

Table II

Incidence rate of AKI for each group.

GroupCases of AKI, n (ESUR)Incidence of AKI (ESUR, n %)P-valueaCases of AKI, n (KDIGO)Incidence of AKI (KDIGO, n %) P-valuea
SHAM-- -- 
CM840% (8/20)0.055525% (5/20)0.1066
IRI735% (7/20)b<0.05525% (5/20)0.1066
CM-IRI1575% (15/20) 1155% (11/20) 

[i] aχ with Yates' continuity correction.

[ii] bP<0.05 vs. CM-IRI. AKI, Acute kidney injury; ESUR, European society of urogenital radiology; KDIGO, kidney disease improving global outcomes; CM, contrast media; IRI, ischemia reperfusion injury.

Renal histopathological results

SHAM group showed a normal structure with complete glomerular structure and no proximal or distal renal tubule damage, no obvious interstitial edema, cell debris and presence of protein tubule (Fig. 4A, E). However, CM (Fig. 4B, F), IRI group (Fig. 4C, G) and CM-IRI group (Fig. 4D, H) displayed multiple kinds of renal tubular injury, including glomerular structure destruction, interstitial edema, swelling of distal convoluted tubules, protein degeneration and formation of protein tubes.

Figure 4

Representative photomicrographs of tubular cell injury in the SHAM, CM, IRI and CM-IRI groups. (A) SHAM group showed a normal structure with complete glomerular structure and no proximal or distal renal tubule damage. (B) CM group showed multiple renal tubular injury and protein degeneration. (C) IRI group showed multiple renal tubular injury including glomerular structure destruction and interstitial edema. (D) CM-IRI group showed multiple renal tubular injury including protein degeneration, swelling of distal convoluted tubules and interstitial edema. (E) SHAM groups show a micrograph of the normal and intact renal structures. (F) CM groups show the formation of protein tubes. (G) IRI groups show edema injury in the glomerulus. (H) CM-IRI groups shows indicate protein degeneration. Top row magnification, x40 (scale bar, 100 µm); bottom row magnification, x200 (scale bar, 20 µm). CM, contrast media; IRI, ischemia reperfusion injury.

The expression of AKI biomarkers and oxidative stress index

We next examined the expression of AKI biomarkers and levels of oxidative stress in renal tissues. Western blot analyses indicated NGAL and KIM-1 levels in the CM-IRI group increased significantly (Fig. 5A-C), with the CM-IRI group shows a statistically increased than CM and IRI group. IHC was used to detect the expression and distribution of NGAL in renal tissue. Compared with the SHAM group, the expression of NGAL significantly increased in the CM, IRI, and CM-IRI groups and the positive rate was the highest in the CM-IRI group (Fig. 5D-E). The level of oxidative stress was measured by ROS expression in kidney tissues. CM, IRI, and CM-IRI groups showed higher ROS levels than sham group, with the CM-IRI group shows statistically increased than CM and IRI group (Fig. 6).

Figure 5

Western blotting and quantified analysis of renal injury biomarkers. (A) Representative blots of NGAL and KIM-1 protein expression. (B) Quantification on NGAL relative expression. (C) Quantification on KIM-1 relative expression. (D) The expression of NGAL was detected by immunohistochemistry. Row magnification, x100 (scale bar, 50 µm). (E) Quantification on the positive area. *P<0.05, **P<0.01, ***P<0.001 vs. SHAM group; #P<0.05, ###P<0.001 vs. CM-IRI group). NGAL, neutrophil gelatinase-associated lipocalin; CM, contrast media; IRI, ischemia reperfusion injury.

Figure 6

Level of oxidative stress in renal tissue. Representative the level of ROS on each group in renal tissue. ***P<0.001 vs. SHAM group; ###P<0.001 vs. CM-IRI group. ROS, reactive oxygen species; CM, contrast media; IRI, ischemia reperfusion injury.

Discussion

The present study aimed to establish a post-AMI AKI model and investigate the stability of model by assessing the expression of AKI biomarkers, level of renal injury and oxidative stress. Our study shows that CM combined IRI surgery has a higher postoperative AKI rate than single factor induced AKI, as well as more severe renal damage in pathology and a high level of oxidative stress in pathophysiology, indicating that oxidative stress injury may play a significant role in post-AMI AKI.

Various preoperative risk factors and mechanisms have been related to post-AMI AKI, including preoperative declining kidney function, and excessive use of intraoperative contrast media, in which contrast media induced renal hypoperfusion and hypovolemia are pivotal elements in pathophysiology (15). During the PCI surgery, heart vessels are exposed to a high dose of contrast media, which is later eliminated by the kidney. Firstly, contrast media in the circulation will be filtered through the glomeruli and as it progressively passed through the renal tubules, the concentration of contrast media in the distal convoluted tubules will gradually increase (16). Meanwhile, the viscosity of the fluid in the renal tubules increased due to the elevated concentration of CM, which prolonged kidney exposure to contrast media, resulting in congestion of the tubules and reduced kidney blood flow. This process may be affected by the amount of contrast media, the character of contrast media, and perioperative venous hydration. Previous studies show that physicochemical properties of contrast media can also cause renal vasoconstriction and hemodynamic change, causing renal hypoperfusion. Under high osmotic conditions, plasma water flows from vascular lumen to interstitium, resulting in enrichment of contrast media in vasa recta, thereby increasing local blood viscosity and local vascular resistance. Meanwhile, high osmosis can increase urate levels, resulting in renal tubular obstruction and poor drainage (17).

Furthermore, the state of basic renal function acts as a major contributor to the development of kidney injury. In the study of Cheng et.al, the CI-AKI model was constructed with furosemide combined contrast media demonstrated that dehydration 24 to 48 h before surgery or using diuretics prior to surgery can reduce basic renal function and more effectively induce AKI (18). In dehydrated individuals, most of the water is reabsorbed by the renal tubules during elimination of contrast media, leaving the high viscosity of contrast media that may cause damage to renal tubular epithelial cells. However, the AKI rate in the CM-induced AKI models is relatively low and solely concentrates on one organ. As a result, our research focuses on developing an animal model of a contrast agent associated with IRI surgery that is similar to the incidence of AKI in clinical patients following PCI or CAG and also better investigates the connection between the heart and kidney. Therefore, based on previous research on the AKI model, we used ioprolamine, a commonly used contrast media in clinical practice to construct our model. All the rats were dehydrated 24 h before surgery as a pre-treating procedure. Consistent with previous research, the model of contrast media after dehydration alone had a low postoperative AKI rate of around 30% (19). Given extended postoperative nursing time increases rat mortality, we collected blood, heart, and kidney 24 h following surgery. Compared with other traditional 72-h animal modeling methods, 24 h was sufficient for rats to meet AKI standards. In the meantime, the postoperative nursing time for the rats was reduced, which contributed to shortening the animal modeling cycle.

However, not all AKI observed after exposure to contrast media are caused by the contrast media itself, pathological processes that occur during coronary ischemia-reperfusion may also lead to kidney injury. During myocardial infarction, blood vessels of other organs contract to compensate for the decreased blood volume caused by the infarcted coronary artery (17). As an organ with a high blood volume, the kidney may reduce the effective blood volume to support and maintain the basis cardiac function. Besides, harmful substances are released into the circulation due to multiple organ injuries caused by myocardial ischemia-reperfusion, these harmful substances may cause an additional injury by the absorption of the kidney (20). As a result, we combine the preoperative use of a contrast media with coronary ischemia reperfusion surgery to established the post-AMI AKI model. This model can better observe the effect of CM and IRI surgery on kidney injury, which is compatible with the disease background of post-AMI AKI. Under the double effects of CM and IRI surgery on kidney blood volume and kidney function, the incidence rate of AKI in the CM-IRI group is significantly higher than that of the other two groups.

Clinically, there are two main ways to define AKI patients: ESUR and KDIGO criteria and using clinical criteria can better compare the AKI modeling rate between groups. Based on the ESUR definition, 15 rats in the CM-IRI group met the criteria. And based on the KDIGO definition, only 11 rats in the CM-IRI group met the criteria. Because the KDIGO criterion standard is more stringent than the others, the number of AKI under this threshold is smaller. The CM-IRI group had the highest incidence of AKI in both definitions, indicating that contrast media combined with IRI operation produced more stimulation in rats.

Recent research has demonstrated the importance of oxidative stress in AKI (21,22). Excessive production of reactive oxygen species (ROS) causes oxidative damage to mitochondria and lipids (23). Quintavalle et al. demonstrated that CM may result in a dose-response increase in reactive oxygen species production, which activates Jun N-terminal kinases (JNK1/2) and p38 stress kinases (24). In our study, markers of oxidative stress such as ROS were significantly increased in the CM-IRI group. Similar results were observed in AKI biomarkers, NGAL and KIM-1 are biomarkers of early renal injury and are highly expressed in kidney tissue of the CM-IRI group. The results of creatinine and expression of biomarkers in the kidney were consistent with the increased expression of ROS suggesting contrast media can exacerbated acute kidney injury caused by IRI through oxidative stress. And elevated oxidative stress levels could be the cause of CM-IRI group had the highest number of postoperative AKI.

This model has some limitations. First, our rats were dehydrated for 24 h before surgery as a pre-treatment, and multiple dehydration time points or diuretic can be added to the model to further reduce renal function. Second, the occurrence of AMI in our models was determined by an elevated ST segment in an electrocardiogram. Thus, from the perspective of disease, the animal model of myocardial infarction in our study is more similar to STEMI patients in clinical practice. In our study, we used ROS as the primary indicator of oxidative stress. But some secondary indicators, like MDA or CAT, can also be used to investigate oxidative stress, and their importance shouldn't be overlooked. Therefore, the detection of these secondary indicators can be considered in subsequent experiments to comprehensively evaluate oxidative stress. Finally, based on the KDIGO standard, the number of AKI rats was small. As a consequence, animal research needs to be improved further, such as expanding sample size as well as including result analysis at different time points.

In conclusion, we established a reliable and stable animal model by combined CM with IRI surgery, the model has a high rate of postoperative AKI and our model can better simulate clinical features of post-AMI AKI. Meanwhile, we proved the important role of oxidative stress in our model by detecting ROS levels. Combined with the detection of kidney injury indicators such as NGAL and KIM-1, we demonstrated that contrast media can exacerbate acute kidney injury caused by IRI through oxidative stress and cause more severe kidney damage in rats. Our study provides an animal model basis for further exploring the pathogenesis of the disease. And this work emphasized that reducing oxidative stress levels may be a potential approach to preventing or treating the disease of post-AMI AKI.

Acknowledgements

Not applicable.

Funding

Funding: Financial support for the research, authorship, and/or publication of this article was received from: Guangdong Provincial Science and Technology Project (grant no. KJ022021049); Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention (grant no. Y0120220151); General Program of Hainan Natural Science Foundation (grant no. 818MS132); Key Laboratory of Emergency and Trauma (Hainan Medical University), Ministry of Education (grant no. KLET-202116) and NSFC Incubation Project of Guangdong Provincial People's Hospital (grant no. KY0120220041).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

SY and JC conceived and designed the study. XD, WL and HL collected data and performed animal surgery. YX wrote the original draft and performed analysis and interpretation of data. YZ, KH and JLia analyzed data and the statistical analysis. JX, JLiu and YL made substantial contributions to the conception and acquisition of data. YL and JC confirm the authenticity of all the raw data. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The study protocol was approved by the Animal Ethics Committee of Guangdong Provincial People's Hospital (approval no. GDRECKY2020-266-01).

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS and Spertus JA: Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: Insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 7:1–9. 2014.PubMed/NCBI View Article : Google Scholar

2 

Tao J, Dai W, Ye C, Yao Q, Zhou M and Li Y: Preprocedural Lp(a) level and ApoB/ApoA-Ι ratio and the risk for contrast-induced acute kidney injury in patients undergoing emergency PCI. Lipids Health Dis. 20(130)2021.PubMed/NCBI View Article : Google Scholar

3 

Anzai A, Anzai T, Naito K, Kaneko H, Mano Y, Jo Y, Nagatomo Y, Maekawa Y, Kawamura A, Yoshikawa T and Ogawa S: Prognostic significance of acute kidney injury after reperfused ST-elevation myocardial infarction: Synergistic acceleration of renal dysfunction and left ventricular remodeling. J Card Fail. 16:381–389. 2010.PubMed/NCBI View Article : Google Scholar

4 

Khoury S, Margolis G, Ravid D, Rozenbaum Z, Keren G and Shacham Y: Outcomes of early and reversible renal impairment in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 9:684–689. 2020.PubMed/NCBI View Article : Google Scholar

5 

Marenzi G, Cosentino N, Milazzo V, De Metrio M, Rubino M, Campodonico J, Moltrasio M, Marana I, Grazi M, Lauri G, et al: Acute kidney injury in diabetic patients with acute myocardial infarction: Role of acute and chronic glycemia. J Am Heart Assoc. 7(e008122)2018.PubMed/NCBI View Article : Google Scholar

6 

Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT and Wiviott SD: Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: A report from the national cardiovascular data registry. Circulation. 125:497–504. 2012.PubMed/NCBI View Article : Google Scholar

7 

Xie XC, Cao Y, Yang X, Xu QH, Wei W and Wang M: Relaxin attenuates contrast-induced human proximal tubular epithelial cell apoptosis by activation of the PI3K/Akt signaling pathway in vitro. Biomed Res Int. 2017(2869405)2017.PubMed/NCBI View Article : Google Scholar

8 

Zhao L, Hu C, Zhang P, Jiang H and Chen J: Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury. Stem Cell Res Ther. 9(225)2018.PubMed/NCBI View Article : Google Scholar

9 

Li Z, Wu J, Wei W, Cai X, Yan J, Song J, Wang C and Wang J: Association of serum miR-186-5p with the prognosis of acute coronary syndrome patients after percutaneous coronary intervention. Front Physiol. 10(686)2019.PubMed/NCBI View Article : Google Scholar

10 

Besseling PJ, Pieters TT, Nguyen ITN, de Bree PM, Willekes N, Dijk AH, Bovée DM, Hoorn EJ, Rookmaaker MB, Gerritsen KG, et al: A plasma creatinine- and urea-based equation to estimate glomerular filtration rate in rats. Am J Physiol Renal Physiol. 320:F518–F524. 2021.PubMed/NCBI View Article : Google Scholar

11 

Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Almén T, Aspelin P, Bellin MF, Clement O, et al: Contrast induced nephropathy: Updated ESUR contrast media safety committee guidelines. Eur Radiol. 21:2527–2541. 2011.PubMed/NCBI View Article : Google Scholar

12 

Lameire N and Kellum JA: KDIGO AKI Guideline Work Group. Contrast-induced acute kidney injury and renal support for acute kidney injury: A KDIGO summary (part 2). Crit Care. 17(205)2013.PubMed/NCBI View Article : Google Scholar

13 

Cheng H, Fan X, Lawson WE, Paueksakon P and Harris RC: Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy. Kidney Int. 88:85–94. 2015.PubMed/NCBI View Article : Google Scholar

14 

Liu YH, Xue JH, Wu DX, Bei WJ, Wang K, Liu Y, Chen JY and Tan N: A novel simple experimental model for low-osmolar contrast-induced acute kidney injury using different definitions based on the levels of serum creatinine and cystatin C. BMC Nephrol. 20(243)2019.PubMed/NCBI View Article : Google Scholar

15 

Zhou Q, Zhao C, Xie D, Xu D, Bin J, Chen P, Liang M, Zhang X and Hou F: Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: Impact on outcomes. BMC Nephrol. 13(51)2012.PubMed/NCBI View Article : Google Scholar

16 

Jost G, Lengsfeld P, Lenhard DC, Pietsch H, Hütter J and Sieber MA: Viscosity of iodinated contrast agents during renal excretion. Eur J Radiol. 80:373–377. 2011.PubMed/NCBI View Article : Google Scholar

17 

Ye Z, Lu H, Su Q, Guo W, Dai W, Li H, Yang H and Li L: Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis. Medicine (Baltimore). 96(e6059)2017.PubMed/NCBI View Article : Google Scholar

18 

Cheng W, Zhao F, Tang CY, Li XW, Luo M and Duan SB: Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model. Arch Toxicol. 92:2245–2257. 2018.PubMed/NCBI View Article : Google Scholar

19 

Sharma A, Kilari S, Cai C, Simeon ML and Misra S: Increased fibrotic signaling in a murine model for intra-arterial contrast-induced acute kidney injury. Am J Physiol Renal Physiol. 318:F1210–F1219. 2020.PubMed/NCBI View Article : Google Scholar

20 

Hašková P, Jansová H, Bureš J, Macháček M, Jirkovská A, Franz KJ, Kovaříková P and Šimůnek T: Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury. Toxicology. 371:17–28. 2016.PubMed/NCBI View Article : Google Scholar

21 

Rubinstein I, Abassi Z, Milman F, Ovcharenko E, Coleman R, Winaver J and Better OS: Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: A possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrol Dial Transplant. 24:428–436. 2009.PubMed/NCBI View Article : Google Scholar

22 

Tanaka S, Sugiura Y, Saito H, Sugahara M, Higashijima Y, Yamaguchi J, Inagi R, Suematsu M, Nangaku M and Tanaka T: Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice. Kidney Int. 94:912–925. 2018.PubMed/NCBI View Article : Google Scholar

23 

Boekhoud L, Koeze J, van der Slikke EC, Bourgonje AR, Moser J, Zijlstra JG, Muller Kobold AC, Bulthuis MLC, van Meurs M, van Goor H, et al: Acute kidney injury is associated with lowered plasma-free thiol levels. Antioxidants (Basel). 9(1135)2020.PubMed/NCBI View Article : Google Scholar

24 

Quintavalle C, Brenca M, De Micco F, Fiore D, Romano S, Romano MF, Apone F, Bianco A, Zabatta MA, Troncone G, et al: In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. Cell Death Dis. 2(e155)2011.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yu S, Dong X, Lai W, Lu H, Xie Y, Xu J, Zeng Y, Han K, Liang J, Liu J, Liu J, et al: Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery. Exp Ther Med 26: 321, 2023.
APA
Yu, S., Dong, X., Lai, W., Lu, H., Xie, Y., Xu, J. ... Chen, J. (2023). Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery. Experimental and Therapeutic Medicine, 26, 321. https://doi.org/10.3892/etm.2023.12020
MLA
Yu, S., Dong, X., Lai, W., Lu, H., Xie, Y., Xu, J., Zeng, Y., Han, K., Liang, J., Liu, J., Liu, Y., Chen, J."Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery". Experimental and Therapeutic Medicine 26.1 (2023): 321.
Chicago
Yu, S., Dong, X., Lai, W., Lu, H., Xie, Y., Xu, J., Zeng, Y., Han, K., Liang, J., Liu, J., Liu, Y., Chen, J."Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery". Experimental and Therapeutic Medicine 26, no. 1 (2023): 321. https://doi.org/10.3892/etm.2023.12020
Copy and paste a formatted citation
x
Spandidos Publications style
Yu S, Dong X, Lai W, Lu H, Xie Y, Xu J, Zeng Y, Han K, Liang J, Liu J, Liu J, et al: Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery. Exp Ther Med 26: 321, 2023.
APA
Yu, S., Dong, X., Lai, W., Lu, H., Xie, Y., Xu, J. ... Chen, J. (2023). Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery. Experimental and Therapeutic Medicine, 26, 321. https://doi.org/10.3892/etm.2023.12020
MLA
Yu, S., Dong, X., Lai, W., Lu, H., Xie, Y., Xu, J., Zeng, Y., Han, K., Liang, J., Liu, J., Liu, Y., Chen, J."Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery". Experimental and Therapeutic Medicine 26.1 (2023): 321.
Chicago
Yu, S., Dong, X., Lai, W., Lu, H., Xie, Y., Xu, J., Zeng, Y., Han, K., Liang, J., Liu, J., Liu, Y., Chen, J."Establishment and assessment of a preclinical model of acute kidney injury induced by contrast media combined acute myocardial ischemia reperfusion surgery". Experimental and Therapeutic Medicine 26, no. 1 (2023): 321. https://doi.org/10.3892/etm.2023.12020
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team